Categories: News

EFGH Appoints Veteran Media Strategist Woon Tai Ho to Board of Advisors to Shape Global Narrative and Trust

SINGAPORE, Oct. 1, 2025 /PRNewswire/ — Embed Financial Group Holdings (EFGH) today announced the appointment of veteran media strategist, author and producer Woon Tai Ho to its Board of Advisors. The move reinforces EFGH’s commitment to trust, clarity and influence as it expands across Asia and Africa.

- Advertisement -

Woon is best known for leading the team that launched Channel NewsAsia, a milestone that helped position Singapore as a hub for regional news. Over more than three decades he has advised ministries, regional governments, multinational corporations and public figures on reputation management and crisis communications. In 2024 he was inducted into the Singapore Media Industry Hall of Fame, recognising his lasting contribution to the media landscape.

- Advertisement -

An accomplished author and producer, Woon’s George Yeo: Musings series has sold more than 30,000 copies. His book Soul of Ink: Lim Tze Peng at 100 received the inaugural Dr Alan HJ Chan Spirit of Singapore Book Prize in 2024. He continues to champion visual communication through documentaries, profiles and corporate films that bring clarity to complex issues.

- Advertisement -

Dennis Ng, Executive Chairman of EFGH, said:

- Advertisement -

“Tai Ho has spent his career building public trust through clear, credible communication. EFGH is building systems that people can rely on, and that mission depends on trust. His leadership in narrative and reputation will help EFGH communicate with authority as we scale globally.”

- Advertisement -

Woon Tai Ho said:

- Advertisement -

“Finance is ultimately about people, trust and connection. EFGH is creating the infrastructure that turns those values into everyday reality for communities across Asia and Africa. I am glad to contribute to shaping a global narrative that is grounded, credible and focused on impact.”

- Advertisement -

With this appointment, EFGH strengthens its leadership for the next phase of growth. The company is building the financial internet of protection, credit, payments and remittances, while advancing financial literacy so communities can make informed decisions.

- Advertisement -

About EFGH

- Advertisement -

Founded in 2024 and headquartered in Singapore, EFGH is a Finternet company that builds the digital plumbing of financial services across Asia and Africa. By embedding protection, credit, payments and remittances into everyday systems, EFGH helps underinsured and underserved communities build security and opportunity.

- Advertisement -

Photo – https://mma.prnewswire.com/media/2786794/EFGH_Woon_Tai_Ho_Non_Executive_of_Global_Advisory_Board_Post.jpg

- Advertisement -

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/efgh-appoints-veteran-media-strategist-woon-tai-ho-to-board-of-advisors-to-shape-global-narrative-and-trust-302572222.html

- Advertisement -

Recent Posts

FemiCore (Official Website & Authenticity Notice 2026) Counterfeit Risks and What Consumers Should Know

New York City, NY, June 13, 2026 (GLOBE NEWSWIRE) -- The women's health supplement market…

4 hours ago

Hitch Open Ping-Pong Embodied (HOPE) AI Challenge Joins the 2026 World Humanoid Robot Games, Seeding Advanced Physical AI Against Human Performance

BEIJING, June 13, 2026 (GLOBE NEWSWIRE) -- The 2026 Hitch Open Ping-Pong Embodied AI Challenge…

4 hours ago

Crypto News Today: AlphaPepe Unveils AlphaSwap Early Access as Bitcoin Price Prediction Eyes $250,000

MONACO, June 12, 2026 (GLOBE NEWSWIRE) -- Crypto news today is turning toward AlphaPepe after…

4 hours ago

Hexaware Expands Presence in Gujarat with New Delivery Center at GIFT City

MUMBAI, India, LONDON and ISELIN, N.J., June 13, 2026 /PRNewswire/ -- Hexaware Technologies [NSE: HEXT], a…

6 hours ago

Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026

 -- Patients with PWS treated with setmelanotide therapy (N=17) achieved clinically meaningful BMI or BMI…

7 hours ago

Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema

June 13, 2026 07:30 ET  | Source: Intellia Therapeutics, Inc. Data from HAELO Phase 3…

7 hours ago